SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-034284
Filing Date
2020-03-16
Accepted
2020-03-16 21:17:52
Documents
2
Period of Report
2020-03-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2012902-1_form4.html 4  
1 FORM 4 tm2012902-1_form4.xml 4 6205
2 EXHIBIT 24 tm2012902-1_ex24.htm EX-24 9697
  Complete submission text file 0001104659-20-034284.txt   17598
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 16760 SW UPPER BOONES FERRY RD SUITE 101 PORTLAND X1 97224
Business Address
Burns John Thomas (Reporting) CIK: 0001568734 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 20719058